Back to URGN

SILVERARC CAPITAL MANAGEMENT, LLC → URGN

SILVERARC CAPITAL MANAGEMENT, LLC URGN Position History

UroGen Pharma Ltd. • Healthcare

Quarters held
4
Latest value
$46.7M
Q3 2026
Peak value
$47.9M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$40.7M
Q1 2026$27M
Q2 2026$47.9M
Q3 2026$46.7M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$46.7M1.15M——
Q2 2026$47.9M1.30M——
Q1 2026$27M1.50M——
Q4 2025$40.7M1.74M——

Other funds holding URGN

Other SILVERARC CAPITAL MANAGEMENT, LLC positions

KOD

KODIAK SCIENCES INC

$71.1M
CELC

CELCUITY INC

$63.9M
KALU

KALVISTA PHARMACEUTICALS INC

$57.9M
AAVXF

ABIVAX SA

$56.9M
ASND

ASCENDIS PHARMA A/S

$55M
DNTH

DIANTHUS THERAPEUTICS INC

$54.9M
CELC

CELCUITY INC

$52.4M
COGT

COGENT BIOSCIENCES INC

$50.6M